主动脉瓣狭窄合并冠脉病变:经导管与外科治疗的费用比较
基于美国全国住院患者样本,分析2012至2017年主动脉瓣狭窄合并冠心病患者的住院结局。调整后住院死亡率相当,但TAVR+PCI组心脏及血管并发症率和住院费用更高,尽管住院时间更短。
要点
- TAVR+PCI使用比例从2012年1%增至2017年9.2%(P < .001)。
- 调整后住院死亡率两组相当(OR 0.94;95%CI 0.79-1.11;P = .45)。
- TAVR+PCI组起搏器植入、心脏骤停和血管并发症更高,住院费用更高。
核心结论
- SAVR+CABG与TAVR+PCI的调整后住院死亡率相当,但TAVR+PCI心脏和血管并发症率及住院费用更高。
研究设计与样本
- 基于美国全国住院患者样本(National Inpatient Sample)的回顾性队列研究。
主要发现
- TAVR+PCI比例从2012年1%增至2017年9.2%(P < .001)。
- SAVR+CABG患者更年轻、男性更多、合并症更少(均P < .001)。
- 调整后住院死亡率两组相当(OR 0.94;95%CI 0.79-1.11;P = .45)。
- TAVR+PCI组起搏器植入、心脏骤停和血管并发症率更高,SAVR+CABG组 prolonged ventilation 需求更高。
- TAVR+PCI组住院时间更短、出院回家比例更高,但住院费用更高(均P < .001)。
临床怎么用
- TAVR+PCI可缩短住院时间并提高出院回家比例,但需权衡更高的并发症风险和住院费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical aortic valve replacement with coronary artery bypass grafting (SAVR+CABG) is the recommended treatment for aortic stenosis and coronary artery disease; however, percutaneous coronary intervention at the time of transcatheter aortic valve replacement (TAVR+PCI) is used with increasing frequency. METHODS: Using the National Inpatient Sample, we identified all adult admissions with a diagnosis of aortic stenosis. Subgroups of SAVR+CABG and TAVR+PCI formed the study group. Outcomes of interest included total hospitalization charges, temporal trends, in-hospital mortality, and complications. RESULTS: Between 2012 and 2017, a total of 97 955 admissions (95.9%) received SAVR+CABG, and 4240 (4.1%) received TAVR+PCI; the proportion of TAVR+PCI increased from 1% in 2012 to 9.2% in 2017 (P < .001). Compared with patients receiving TAVR+PCI, admissions receiving SAVR+CABG were younger, more likely to be male, and had lower comorbidity (all P < .001). Adjusted in-hospital mortality was comparable in both groups (odds ratio 0.94; 95% confidence interval, 0.79 to 1.11; P = .45). Higher rates of pacemaker implantation, cardiac arrest, and vascular complications were seen in the TAVR+PCI group, whereas SAVR+CABG was associated with a greater requirement for prolonged ventilation. Admissions receiving TAVR+PCI had shorter lengths of hospital stay and were more likely to be discharged home. Nevertheless, the TAVR+PCI group had higher hospitalization charges compared with the SAVR+CABG group (all P < .001). CONCLUSIONS: There has been a steady increase in the use of percutaneous strategies for aortic stenosis and coronary artery disease management. In-hospital mortality was comparable in SAVR+CABG and TAVR+PCI groups, but despite shorter in-hospital stays, TAVR+PCI was associated with higher cardiac and vascular complication rates and hospitalization charges.
引用
- Patlolla SH, Schaff HV, Dearani JA, et al. Aortic Stenosis and Coronary Artery Disease: Cost of Transcatheter vs Surgical Management. Ann Thorac Surg. 2021. PMID: 34560043. doi:10.1016/j.athoracsur.2021.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。